Health IT Analytics September 18, 2018
Jennifer Bresnick

Amazon Web Services, Accenture, and Merck are creating a new cloud-based informatics research platform that aims to accelerate drug development.

Amazon Web Services (AWS), Accenture, and Merck have announced a collaboration to create a cloud-based informatics research platform to support advances in the life sciences.

The project will accelerate drug development by improving efficiency and innovation in the early stages of the development process, the companies said in a press release. Researchers will have access to new data aggregation and big data analytics capabilities with lower barriers to entry.

Standard application programming interfaces (APIs) will allow scientists to collaborate more effectively and conduct advanced research across disparate organizations.

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Cloud, Precision Medicine, Technology
Alphabet shares jump 14% on earnings beat, first-ever dividend
Microsoft says cloud AI demand is exceeding supply even after 79% surge in capital spending
IBM to expand cloud offering with $6.4bn HashiCorp deal
Microsoft cloud growth accelerates on back of AI push
IBM to acquire HashiCorp in $6.4 billion deal, reports another revenue miss

Share This Article